{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:44:08Z","timestamp":1794962648335,"version":"4.9.1"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>The coronavirus disease 2019 pandemic continues to affect millions worldwide. Given the rapidly growing evidence base, we implemented a living guideline model to provide guidance on the management of patients with severe or critical coronavirus disease 2019 in the ICU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>The Surviving Sepsis Campaign Coronavirus Disease 2019 panel has expanded to include 43 experts from 14 countries; all panel members completed an electronic conflict-of-interest disclosure form. In this update, the panel addressed nine questions relevant to managing severe or critical coronavirus disease 2019 in the ICU. We used the World Health Organization\u2019s definition of severe and critical coronavirus disease 2019. The systematic reviews team searched the literature for relevant evidence, aiming to identify systematic reviews and clinical trials. When appropriate, we performed a random-effects meta-analysis to summarize treatment effects. We assessed the quality of the evidence using the Grading of Recommendations, Assessment, Development, and Evaluation approach, then used the evidence-to-decision framework to generate recommendations based on the balance between benefit and harm, resource and cost implications, equity, and feasibility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>The Surviving Sepsis Campaign Coronavirus Diease 2019 panel issued nine statements (three new and six updated) related to ICU patients with severe or critical coronavirus disease 2019. For severe or critical coronavirus disease 2019, the panel strongly recommends using systemic corticosteroids and venous thromboprophylaxis but strongly recommends against using hydroxychloroquine. In addition, the panel suggests using dexamethasone (compared with other corticosteroids) and suggests against using convalescent plasma and therapeutic anticoagulation outside clinical trials. The Surviving Sepsis Campaign Coronavirus Diease 2019 panel suggests using remdesivir in nonventilated patients with severe coronavirus disease 2019 and suggests against starting remdesivir in patients with critical coronavirus disease 2019 outside clinical trials. Because of insufficient evidence, the panel did not issue a recommendation on the use of awake prone positioning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>The Surviving Sepsis Campaign Coronavirus Diease 2019 panel issued several recommendations to guide healthcare professionals caring for adults with critical or severe coronavirus disease 2019 in the ICU. Based on a living guideline model the recommendations will be updated as new evidence becomes available.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000004899","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T03:21:27Z","timestamp":1611890487000},"page":"e219-e234","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":343,"title":["Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update"],"prefix":"10.1097","volume":"49","author":[{"given":"Waleed","family":"Alhazzani","sequence":"first","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayez","family":"Alshamsi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Hylander","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital Rigshospitalet, Department of Intensive Care, Copenhagen, Denmark."},{"name":"Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Ostermann","sequence":"additional","affiliation":[{"name":"Department of Critical Care, King\u2019s College London, Guy\u2019s & St Thomas\u2019 Hospital, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hallie C.","family":"Prescott","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Michigan, Ann Arbor and VA Ann Arbor Healthcare System, Ann Arbor, MI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaseen M.","family":"Arabi","sequence":"additional","affiliation":[{"name":"Intensive Care Department, Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Loeb","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Ng Gong","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Division of Pulmonary Medicine, Department of Medicine, Montefiore Healthcare System\/Albert Einstein College of Medicine, The Bronx, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Fan","sequence":"additional","affiliation":[{"name":"Interdepartmental Division of Critical Care Medicine and the Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Oczkowski","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell M.","family":"Levy","sequence":"additional","affiliation":[{"name":"Warren Alpert School of Medicine at Brown University, Providence, RI."},{"name":"Rhode Island Hospital, Providence, RI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennie","family":"Derde","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands."},{"name":"Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Dzierba","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Du","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Complex, Severe, and Rare Diseases, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Machado","sequence":"additional","affiliation":[{"name":"Anaesthesiology, Pain and Intensive Care Department, Universidade Federal de Sao Paulo, Sao Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Wunsch","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada."},{"name":"Department of Anesthesia and Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Crowther","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cecconi","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center\u2013IRCCS, Rozzano (Mi), Italy."},{"name":"Humanitas University, Department of Biomedical Sciences, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younsuck","family":"Koh","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Burry","sequence":"additional","affiliation":[{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Chertow","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, National Institutes of Health Clinical Center and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Szczeklik","sequence":"additional","affiliation":[{"name":"Center for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krak\u00f3w, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Belley-Cote","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"Population Health Research Institute, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Greco","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center\u2013IRCCS, Rozzano (Mi), Italy."},{"name":"Humanitas University, Department of Biomedical Sciences, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Bala","sequence":"additional","affiliation":[{"name":"Chair of Epidemiology and Preventive Medicine, Department of Hygiene and Dietetics, Jagiellonian University Medical College, Krak\u00f3w, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Zarychanski","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Kesecioglu","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"McGeer","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Mermel","sequence":"additional","affiliation":[{"name":"Warren Alpert School of Medicine at Brown University, Providence, RI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj J.","family":"Mammen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Nainan Myatra","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Arrington","sequence":"additional","affiliation":[{"name":"Houston Children\u2019s Hospital, Baylor College of Medicine, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Kleinpell","sequence":"additional","affiliation":[{"name":"Vanderbilt University School of Nursing, Nashville, TN and Rush University College of Nursing, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Citerio","sequence":"additional","affiliation":[{"name":"School of Medicine and Surgery, Milano-Bicocca University, Milano, Italy."},{"name":"ASST-Monza, San Gerardo Hospital, Monza, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bridges","sequence":"additional","affiliation":[{"name":"Biobehavioral Nursing and Health Informatics\u2013University of Washington School of Nursing\/University of Washington Medical Center, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Memish","sequence":"additional","affiliation":[{"name":"Director, Research & Innovation Centre, King Saud Medical City, Ministry of Health & College of Medicine, Alfaisal University, Riyadh, Kingdom of Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Hammond","sequence":"additional","affiliation":[{"name":"Critical Care Division, The George Institute for Global Health and UNSW, Sydney, NSW, Australia."},{"name":"Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick G.","family":"Hayden","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, School of Medicine, Charlottesville, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Alshahrani","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care, Imam Abdulrahman Ben Faisal University, Dammam, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Al Duhailib","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada."},{"name":"Department of Critical Care Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg S.","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine and Grady Memorial Hospital, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis J.","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, University of Pennsylvania; Department of Surgery; Division of Traumatology, Surgical Critical Care and Emergency Surgery, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig M.","family":"Coopersmith","sequence":"additional","affiliation":[{"name":"Department of Surgery and Emory Critical Care center, Emory University School of Medicine, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Antonelli","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology Intensive Care and Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy."},{"name":"Istituto di Anestesiologia e Rianimazione, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Rhodes","sequence":"additional","affiliation":[{"name":"Adult Critical Care, St George\u2019s University Hospitals NHS Foundation Trust & St George\u2019s University of London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.1097\/CCM.0000000000004363","article-title":"Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19).","volume":"48","author":"Alhazzani","year":"2020","journal-title":"Crit Care Med"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s00134-020-06022-5","article-title":"Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19).","volume":"46","author":"Alhazzani","year":"2020","journal-title":"Intensive Care Med"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.09.009","article-title":"GRADE evidence to decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT.","volume":"81","author":"Sch\u00fcnemann","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/00000542-198906000-00002","article-title":"Position and motion of the human diaphragm during anesthesia-paralysis.","volume":"70","author":"Krayer","year":"1989","journal-title":"Anesthesiology"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1164\/ajrccm.161.5.9901037","article-title":"The prone position eliminates compression of the lungs by the heart.","volume":"161","author":"Albert","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R6-20250502","first-page":"528","article-title":"Regional intrapulmonary gas distribution in awake and anesthetized-paralyzed prone man.","volume":"45","author":"Rehder","year":"1978","journal-title":"J Appl Physiol Respir Environ Exerc Physiol"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.resp.2004.02.014","article-title":"Hypoxic pulmonary vasoconstriction is heterogeneously distributed in the prone dog.","volume":"144","author":"Lamm","year":"2004","journal-title":"Respir Physiol Neurobiol"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcrc.2020.08.018","article-title":"Awake prone positioning for COVID-19 hypoxemic respiratory failure: a rapid review.","volume":"61","author":"Weatherald","year":"2021","journal-title":"J Crit Care"},{"key":"R9-20250502","article-title":"Dexamethasone in hospitalized patients with Covid-19: preliminary report.","author":"Horby","year":"2020","journal-title":"N Engl J Med"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","article-title":"Saudi Critical Care Trial Group. Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome.","volume":"197","author":"Arabi","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1164\/rccm.201712-2371ED","article-title":"Systemic corticosteroid therapy may delay viral clearance in patients with Middle East respiratory syndrome coronavirus infection.","volume":"197","author":"Hui","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jcv.2004.07.006","article-title":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients.","volume":"31","author":"Lee","year":"2004","journal-title":"J Clin Virol"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis.","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial:","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"R15-20250502","article-title":"Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19 (Metcovid): a randomised, double-blind, phase IIb, placebo-controlled trial:","author":"Jeronimo","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R16-20250502","first-page":"1","article-title":"COVADIS study group investigators. Impact of late administration of corticosteroids in COVID-19 ARDS.","author":"Mongardon","year":"2020","journal-title":"Intensive Care Med"},{"key":"R17-20250502","first-page":"276","article-title":"Corticosteroids for patients with acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials.","volume":"130","author":"Mammen","year":"2020","journal-title":"Pol Arch Intern Med"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol J"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing esign of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).","volume":"71","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMoa2019014","article-title":"Coalition Covid-19 Brazil I Investigators. Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19.","volume":"383","author":"Cavalcanti","year":"2020","journal-title":"N Engl J Med"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.4269\/ajtmh.20-0873","article-title":"Hydroxychloroquine in the treatment of COVID-19: a multicenter randomized controlled study.","volume":"103","author":"Abd-Elsalam","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa2022926","article-title":"Effect of hydroxychloroquine in hospitalized patients with Covid-19.","volume":"383","author":"Horby","year":"2020","journal-title":"N Engl J Med"},{"key":"R24-20250502","first-page":"ciaa1009","article-title":"BCN PEP-CoV-2 Research Group. Hydroxychloroquine for early treatment of adults with mild Covid-19: a randomized-controlled trial:","author":"Mitj\u00e0","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R25-20250502","first-page":"NEJMoa2023184","article-title":"Repurposed antiviral drugs for COVID-19 \u2013 interim WHO Solidarity trial results.","author":"Pan","year":"2020","journal-title":"N Engl J Med"},{"key":"R26-20250502","article-title":"Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials.","author":"Axfors","journal-title":"medRxiv"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI138003","article-title":"The convalescent sera option for containing COVID-19.","volume":"130","author":"Casadevall","year":"2020","journal-title":"J Clin Invest"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1378\/chest.12-2907","article-title":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A (H1N1) infection.","volume":"144","author":"Hung","year":"2013","journal-title":"Chest"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects.","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.","volume":"52","author":"Hung","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","volume":"145","author":"Luke","year":"2006","journal-title":"Ann Intern Med"},{"key":"R32-20250502","first-page":"489","article-title":"Successful treatment of avian influenza with convalescent plasma.","volume":"12","author":"Kong","year":"2006","journal-title":"Hong Kong Med J"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"Convalescent Plasma Study Group. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J Infect Dis"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"m3939","DOI":"10.1136\/bmj.m3939","article-title":"Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial).","volume":"371","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial:","volume":"324","author":"Li","year":"2020","journal-title":"JAMA"},{"key":"R35-20250502","article-title":"Convalescent plasma for COVID-19: a multicenter, randomized clinical trial:","author":"Avendano-Sola","journal-title":"medRxiv"},{"key":"R37-20250502","article-title":"Convalescent plasma for COVID-19. A randomized clinical trial:","author":"Gharbharan","journal-title":"medRxiv"},{"key":"R38-20250502","first-page":"NEJMoa2031304","article-title":"PlasmAr Study Group. A randomized trial of convalescent plasma in Covid-19 severe pneumonia.","author":"Simonovich","year":"2020","journal-title":"N Engl J Med"},{"key":"R39-20250502","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.mayocp.2020.06.028","article-title":"Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients.","volume":"95","author":"Joyner","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"R40-20250502","first-page":"ciaa1280","article-title":"Singapore 2019 Novel Coronavirus Outbreak Research Team. Viral dynamics and immune correlates of COVID-19 disease severity.","author":"Young","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R41-20250502","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"R42-20250502","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-2423-5","article-title":"Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.","volume":"585","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"R43-20250502","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"ACTT-1 Study Group Members. Remdesivir for the treatment of Covid-19: final report.","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"R44-20250502","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial:","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"R45-20250502","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"GS-US-540-5774 Investigators. Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial:","volume":"324","author":"Spinner","year":"2020","journal-title":"JAMA"},{"key":"R46-20250502","first-page":"m3379","article-title":"A living WHO guideline on drugs for covid-19.","volume":"370","author":"Siemieniuk","year":"2020","journal-title":"BMJ"},{"key":"R47-20250502","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19.","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"R48-20250502","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/his.14134","article-title":"Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction.","volume":"77","author":"Menter","year":"2020","journal-title":"Histopathology"},{"key":"R49-20250502","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M20-2003","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study.","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann Intern Med"},{"key":"R50-20250502","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.thromres.2020.08.020","article-title":"Venous thromboembolism in patients with COVID-19: systematic review and meta-analysis.","volume":"196","author":"Porfidia","year":"2020","journal-title":"Thromb Res"},{"key":"R51-20250502","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1097\/CCM.0b013e31828cf104","article-title":"Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials.","volume":"41","author":"Alhazzani","year":"2013","journal-title":"Crit Care Med"},{"key":"R52-20250502","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016.","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"key":"R53-20250502","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00134-015-3840-z","article-title":"Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis.","volume":"41","author":"Beitland","year":"2015","journal-title":"Intensive Care Med"},{"key":"R54-20250502","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.thromres.2020.09.026","article-title":"Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID).","volume":"196","author":"Lemos","year":"2020","journal-title":"Thromb Res"},{"key":"R55-20250502","doi-asserted-by":"crossref","first-page":"e1087","DOI":"10.1097\/CCM.0000000000004548","article-title":"Higher intensity thromboprophylaxis regimens and pulmonary embolism in critically ill coronavirus disease 2019 patients.","volume":"48","author":"Taccone","year":"2020","journal-title":"Crit Care Med"},{"key":"R56-20250502","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19.","volume":"76","author":"Paranjpe","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R57-20250502","article-title":"Therapeutic anticoagulation is associated with decreased mortality in mechanically ventilated COVID-19 patients.","author":"Trinh","journal-title":"medRxiv"},{"key":"R58-20250502","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.2020.13372","article-title":"Thrombosis in hospitalized patients with COVID-19 in a New York City health system.","volume":"324","author":"Bilaloglu","year":"2020","journal-title":"JAMA"},{"key":"R59-20250502","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.2020006520","article-title":"COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.","volume":"136","author":"Al-Samkari","year":"2020","journal-title":"Blood"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:31:48Z","timestamp":1746192708000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000004899","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,28]]}}}